Oncolys BioPharma Inc.
オンコリスバイオファーマ株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4588
FY2025 · 2025-12-31
| Gross margin | 100.0% |
| Operating margin | -7090.5% |
| Net margin | -7209.6% |
| Return on equity | — |
| Return on assets | -45.2% |
| Revenue growth (YoY) | -9.0% |
| EPS (basic) | ¥-80 |
| EPS growth (YoY) | — |
| Current ratio | 9.55x |
| Equity ratio | 87.6% |
| Book value / share | ¥136.38 |
| Free cash flow | -1,944 M |